A detailed history of Entry Point Capital, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 1,503 shares of MEDP stock, worth $500,213. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,503
Previous 898 67.37%
Holding current value
$500,213
Previous $299,000 66.89%
% of portfolio
0.23%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$308.93 - $363.58 $186,902 - $219,965
605 Added 67.37%
1,503 $499,000
Q3 2024

Nov 13, 2024

BUY
$320.58 - $457.29 $186,577 - $266,142
582 Added 184.18%
898 $299,000
Q2 2024

Aug 13, 2024

BUY
$372.0 - $424.34 $68,076 - $77,654
183 Added 137.59%
316 $130 Million
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $37,887 - $54,970
133 New
133 $53.8 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.